<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03116412</url>
  </required_header>
  <id_info>
    <org_study_id>TRIM</org_study_id>
    <nct_id>NCT03116412</nct_id>
  </id_info>
  <brief_title>A Randomized Trial to Assess the Role of Imaging During Follow up After Radical Surgery of High Risk Melanoma</brief_title>
  <acronym>TRIM</acronym>
  <official_title>A Prospective Randomized Multicenter Trial to Assess the Role of Imaging During Follow up After Radical Surgery of Stage IIb-c and III Cutaneous Malignant Melanoma</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Uppsala University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Uppsala University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      It is not known whether radiological assessments during follow up after surgery for high risk
      melanoma improve survival. Since radiological examinations are resource demanding, could
      inflict worry and cause irradiation exposure it is an important question to address. With the
      introduction of effective medical treatments for malignant melanoma patients, there is a
      tendency to introduce radiological assessments despite the lack of evidence.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The patients are randomized 1:1 to routine follow up for 3 years with regular doctors´
      appointments according to national guidelines and the same follow up but with the addition of
      whole body CT or Positron Emission Tomography (PET) scans and blood tests.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 8, 2017</start_date>
  <completion_date type="Anticipated">December 31, 2024</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2024</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Overall survival</measure>
    <time_frame>At 5 years</time_frame>
    <description>Measured from date of inclusion</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Quality of life/QLQ30</measure>
    <time_frame>During the 3 year intervention period</time_frame>
    <description>Question of Life Questionnaire (QLQ) 30</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of life/HAD</measure>
    <time_frame>During the 3 year intervention period</time_frame>
    <description>Hospital, Anxiety and Depression (HAD) scale</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">1300</enrollment>
  <condition>Malignant Melanoma</condition>
  <arm_group>
    <arm_group_label>Routine follow up</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Follow up according to national guidelines.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Radiological assessments</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Radiological assessments (CT or PET scans) at 5 occasions during 3 years.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>CT or PET scans</intervention_name>
    <description>Scans and blood tests are scheduled at baseline, months 6, 12, 24 and 36.</description>
    <arm_group_label>Radiological assessments</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  At least 18 years of age.

          -  Radical surgery for Cutaneous Malignant Melanoma (CMM) stage IIb-c and III.

          -  Sufficient renal function for i.v. contrast scannings.

        Exclusion Criteria:

          -  The patient is assessed as unfit to receive treatment in the case of recurrence.

          -  Life-expectancy less than 2 years due to concurrent disease (e.g., cardiac disease,
             terminal multiple sclerosis, liver cirrhosis).

          -  Inability to provide informed consent or refusal to do so.

          -  Inability to comply with the control or intense follow-up program.

          -  Participation in other clinical trials interfering with the control-program.

          -  Existing or previous malignancies within the past 5 years (except for in situ breast
             and cervical cancer, melanoma in situ and non-melanoma skin cancer).

          -  Pregnancy or currently planned pregnancy.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Gustav Ullenhag, associate professor</last_name>
    <role>Principal Investigator</role>
    <affiliation>Uppsala University Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Södra Älvsborgs sjukhus</name>
      <address>
        <city>Boras</city>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Lars Larsson</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Mälarsjukhuset Eskilstuna</name>
      <address>
        <city>Eskilstuna</city>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Agneta Nordén</last_name>
      <phone>+4616103343</phone>
      <email>agneta.norden@dll.se</email>
    </contact>
    <investigator>
      <last_name>Antonis Valachis</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Falu lasarett</name>
      <address>
        <city>Falun</city>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anna-Lena Fahlberg</last_name>
      <phone>+46708249653</phone>
      <email>anna-lena.fahlberg@ltdalarna.se</email>
    </contact>
    <investigator>
      <last_name>Ulf Dyrke</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Gävle sjukhus</name>
      <address>
        <city>Gavle</city>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lena Persson</last_name>
      <phone>+4626155423</phone>
      <email>lena.g.persson@regiongavleborg.se</email>
    </contact>
    <investigator>
      <last_name>Olga val Munos</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Helsingborgs lasarett</name>
      <address>
        <city>Helsingborg</city>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Katrin Lange-Norström</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Länssjukhuset Ryhov</name>
      <address>
        <city>Jonkoping</city>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Therese Karlsson</last_name>
      <phone>+46102425962</phone>
      <email>therese.i.karlsson@rjl.se</email>
    </contact>
    <investigator>
      <last_name>Dimitrios Papantoniou</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Länssjukhuset i Kalmar</name>
      <address>
        <city>Kalmar</city>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Lars Gustavsson Wallander</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centralsjukhuset i Karlstad</name>
      <address>
        <city>Karlstad</city>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Eva Sätherberg</last_name>
      <phone>+4654615971</phone>
      <email>eva.satherberg@liv.se</email>
    </contact>
    <investigator>
      <last_name>Lars Ohlsson</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Linköping University Hospital</name>
      <address>
        <city>Linkoping</city>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kerstin Hultgren</last_name>
      <phone>+46101031961</phone>
      <email>kerstin.hultgren@regionostergotland.se</email>
    </contact>
    <contact_backup>
      <last_name>Madeleine Rasic</last_name>
      <phone>+46101035879</phone>
    </contact_backup>
    <investigator>
      <last_name>Braslav Jovanovic</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Sunderby sjukhus</name>
      <address>
        <city>Luleå</city>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Lisa Eskilsson</last_name>
      <phone>+46920280063</phone>
      <email>lisa.eskilsson@norrbotten.se</email>
    </contact>
    <investigator>
      <last_name>Fredrik Riström</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Skåne University Hospital</name>
      <address>
        <city>Lund</city>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gunilla Berggren</last_name>
      <phone>+4646172013</phone>
      <email>gunilla.GB.berggren@skane.se</email>
    </contact>
    <investigator>
      <last_name>Karolin Isaksson</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Örebro University Hospital</name>
      <address>
        <city>Orebro</city>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sofia Axelsson</last_name>
      <phone>+46196022719</phone>
      <email>forskningsskoterska.onk.uso@regionorebrolan.se</email>
    </contact>
    <investigator>
      <last_name>Frida Jakobsson</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Skaraborgs sjukhus Skövde</name>
      <address>
        <city>Skovde</city>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Charlotte Sparring</last_name>
      <phone>+46500432114</phone>
      <email>charlotte.sparring@vgregion.se</email>
    </contact>
    <investigator>
      <last_name>Charlotte Sparring</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Karolinska University Hospital</name>
      <address>
        <city>Stockholm</city>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Leia Ollmar</last_name>
      <phone>+46851779694</phone>
      <email>leia.ollmar@sll.se</email>
    </contact>
    <investigator>
      <last_name>Johan Hansson</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Länssjukhuset Sundsvall</name>
      <address>
        <city>Sundsvall</city>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Carina Eliasson</last_name>
      <phone>+46730315197</phone>
      <email>carina.eliasson@lvn.se</email>
    </contact>
    <investigator>
      <last_name>Petra Flygare</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Uddevalla sjukhus</name>
      <address>
        <city>Uddevalla</city>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Annett Gustafsson</last_name>
      <phone>+46104353371</phone>
      <email>annett.gustafsson@vgregion.se</email>
    </contact>
    <investigator>
      <last_name>Carin Wångblad</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Umeå University Hospital</name>
      <address>
        <city>Umea</city>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Agneta Karhu</last_name>
      <phone>+46907850000</phone>
      <email>agneta.karhu@vll.se</email>
    </contact>
    <investigator>
      <last_name>Malin Jansson</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Akademiska sjukhuset</name>
      <address>
        <city>Uppsala</city>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Camilla Taavo</last_name>
      <phone>+46186111034</phone>
      <email>camilla.taavo@akademiska.se</email>
    </contact>
    <investigator>
      <last_name>Gustav Ullenhag</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Västmanlands sjukhus Västerås</name>
      <address>
        <city>Vasteras</city>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lisa Hultberg</last_name>
      <phone>+4621173000</phone>
      <email>liselotte.hultberg@regionvastmanland.se</email>
    </contact>
    <investigator>
      <last_name>Cecilia Nilsson</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Visby lasarett</name>
      <address>
        <city>Visby</city>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Marie Boberg</last_name>
      <email>marie.boberg01@gotland.se</email>
    </contact>
    <investigator>
      <last_name>Agneta Nordin Danfors</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Sweden</country>
  </location_countries>
  <verification_date>December 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 14, 2017</study_first_submitted>
  <study_first_submitted_qc>April 11, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">April 17, 2017</study_first_posted>
  <last_update_submitted>December 15, 2017</last_update_submitted>
  <last_update_submitted_qc>December 15, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">December 18, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Malignant melanoma</keyword>
  <keyword>Follow up</keyword>
  <keyword>Radiology</keyword>
  <keyword>Survival</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Melanoma</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

